UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

A T-cell-dependent antibody response study using a murine surrogate anti-PD-1 monoclonal antibody as an alternative to a non-human primate model

Journal of immunotoxicology, 2020-01, Vol.17 (1), p.175-185

2020

Link zum Volltext

Verfügbarkeit prüfen

Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression

Oncogene, 2003-06, Vol.22 (23), p.3645-3654

2003

Link zum Volltext

Verfügbarkeit prüfen

Central Nervous System Expression of IL-10 Inhibits Autoimmune Encephalomyelitis

The Journal of immunology (1950), 2001-01, Vol.166 (1), p.602-608

2001

Link zum Volltext

Verfügbarkeit prüfen

Targeted Adenovirus-Induced Expression of IL-10 Decreases Thymic Apoptosis and Improves Survival in Murine Sepsis

Proceedings of the National Academy of Sciences - PNAS, 2001-09, Vol.98 (20), p.11503-11508

2001

Link zum Volltext

Verfügbarkeit prüfen

Molnupiravir maintains antiviral activity against SARS-CoV-2 variants and exhibits a high barrier to the development of resistance

Antimicrobial agents and chemotherapy, 2024-01, Vol.68 (1), p.e0095323

2024

Link zum Volltext

Verfügbarkeit prüfen

Extended Lung Expression and Increased Tissue Localization of Viral IL-10 with Adenoviral Gene Therapy

Proceedings of the National Academy of Sciences - PNAS, 2001-01, Vol.98 (1), p.277-282

2001

Link zum Volltext

Verfügbarkeit prüfen

Cartilage-Specific Matrix and Integrin Expression in Three-Dimensional Articular Chondrocyte Cultures Overexpressing Human Interleukin-10

Clinical medicine insights. Arthritis and musculoskeletal disorders, 2008-01, Vol.2008 (1)

2008

Link zum Volltext

Verfügbarkeit prüfen

Successful Adenovirus-Mediated Wild-Type p53 Gene Transfer in Patients With Bladder Cancer by Intravesical Vector Instillation

Journal of clinical oncology, 2002-02, Vol.20 (4), p.957-965

Kuball, J.

2002

Link zum Volltext

Verfügbarkeit prüfen

Successful Adenovirus-Mediated Wild-Type p53 Gene Transfer in Patients With Bladder Cancer by Intravesical Vector Instillation

Journal of clinical oncology, 2002-02, Vol.20 (4), p.957-965

2002

Link zum Volltext

Verfügbarkeit prüfen

Phase I Trial of Intravesical Recombinant Adenovirus-Mediated Interferon-α2b Formulated in Syn3 for BCG failures in Non-Muscle-Invasive Bladder Cancer

The Journal of urology, 2013-03, Vol.190 (3), p.850-856

2013

Link zum Volltext

Verfügbarkeit prüfen

Increased Survival in Sepsis by In Vivo Adenovirus-Induced Expression of IL-10 in Dendritic Cells

The Journal of immunology (1950), 2002-04, Vol.168 (7), p.3412-3418

2002

Link zum Volltext

Verfügbarkeit prüfen

Characterization of empty capsids from a conditionally replicating adenovirus for gene therapy

Human gene therapy, 2005, Vol.16 (1), p.109-125

2005

Link zum Volltext

Verfügbarkeit prüfen

Characterization of Hemodynamic Events Following Intravascular Infusion of Recombinant Adenovirus Reveals Possible Solutions for Mitigating Cardiovascular Responses

Molecular therapy, 2005-08, Vol.12 (2), p.254-263

2005

Link zum Volltext

Verfügbarkeit prüfen

Adenoviral Delivery of Human and Viral IL-10 in Murine Sepsis

The Journal of immunology (1950), 2001-07, Vol.167 (2), p.1053-1059

2001

Link zum Volltext

Verfügbarkeit prüfen

Working Toward an Adenoviral Vector Testing Standard

Molecular therapy, 2000-12, Vol.2 (6), p.532-534

2000

Link zum Volltext

Verfügbarkeit prüfen

Recombinant adenovirus-transduced human dendritic cells engineered to secrete interleukin-10 (IL-10) suppress Th1-type responses while selectively activating IL-10—producing CD4 + T cells

Human immunology, 2004-11, Vol.65 (11), p.1344-1355

2004

Link zum Volltext

Verfügbarkeit prüfen

Functional modification of dendritic cells with recombinant adenovirus encoding interleukin 10 for the treatment of sepsis

Shock (Augusta, Ga.), 2005-06, Vol.23 (6), p.507-515

2005

Link zum Volltext

Verfügbarkeit prüfen

897. The development of standards for cell and gene therapy products: The activities of the United States pharmacopeia

Molecular therapy, 2004-05, Vol.9 (S1), p.S342-S342

2004

Link zum Volltext

Verfügbarkeit prüfen

Assessment of p53 gene transfer and biological activities in a clinical study of adenovirus-p53 gene therapy for recurrent ovarian cancer

Cancer gene therapy, 2003-03, Vol.10 (3), p.224-238

2003

Link zum Volltext

Verfügbarkeit prüfen

Making the (clinical) grade with adenoviral gene therapy vectors

The quality assurance journal, 1997-09, Vol.2 (3), p.119-127

Hutchins, Beth

1997

Link zum Volltext

Verfügbarkeit prüfen

Extended lung expression and increased tissue localization of viral IL-10 with adenoviral gene therapy

Proceedings of the National Academy of Sciences - PNAS, 2001-01, Vol.98 (1), p.277-282

2001

Link zum Volltext

Verfügbarkeit prüfen

Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models

Cancer gene therapy, 2000-11, Vol.7 (11), p.1469-1480

2000

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(36)

Publikationsform

Sprache

Englisch
(47)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(26)
Life Sciences & Biomedicine
(24)
Humans
(17)
Adenoviridae - Genetics
(13)
Animals
(13)
Female
(12)
Mice
(11)
Adenovirus
(8)
Biological And Medical Sciences
(8)
Interleukin-10 - Genetics
(8)
Biotechnology & Applied Microbiology
(6)
Genetic Therapy
(6)
Genetics & Heredity
(6)
Medicine, Research & Experimental
(6)
Mice, Inbred C57bl
(6)
Research & Experimental Medicine
(6)
Apoptosis
(5)
Genetic Therapy - Methods
(5)
Genetic Vectors - Administration & Dosage
(5)
Immunology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase I Trial of Intravesical Recombinant Adenovirus Mediated Interferon-α2b Formulated in Syn3 for Bacillus Calmette-Guérin Failures in Nonmuscle Invasive Bladder Cancer

A T-cell-dependent antibody response study using a murine surrogate anti-PD-1 monoclonal antibody as an alternative to a non-human primate model

Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression

Central Nervous System Expression of IL-10 Inhibits Autoimmune Encephalomyelitis

Targeted Adenovirus-Induced Expression of IL-10 Decreases Thymic Apoptosis and Improves Survival in Murine Sepsis

Molnupiravir maintains antiviral activity against SARS-CoV-2 variants and exhibits a high barrier to the development of resistance

Phase I Trial of Intravesical Recombinant Adenovirus Mediated Interferon- alpha 2b Formulated in Syn3 for Bacillus Calmette-Guerin Failures in Nonmuscle Invasive Bladder Cancer

Biophysical and Immunological Characterization and In Vivo Pharmacokinetics and Toxicology in Nonhuman Primates of the Anti-PD-1 Antibody Pembrolizumab

Extended Lung Expression and Increased Tissue Localization of Viral IL-10 with Adenoviral Gene Therapy

Cartilage-Specific Matrix and Integrin Expression in Three-Dimensional Articular Chondrocyte Cultures Overexpressing Human Interleukin-10

Successful Adenovirus-Mediated Wild-Type p53 Gene Transfer in Patients With Bladder Cancer by Intravesical Vector Instillation

Successful Adenovirus-Mediated Wild-Type p53 Gene Transfer in Patients With Bladder Cancer by Intravesical Vector Instillation

Phase I Trial of Intravesical Recombinant Adenovirus-Mediated Interferon-α2b Formulated in Syn3 for BCG failures in Non-Muscle-Invasive Bladder Cancer

Increased Survival in Sepsis by In Vivo Adenovirus-Induced Expression of IL-10 in Dendritic Cells

Characterization of empty capsids from a conditionally replicating adenovirus for gene therapy

Characterization of Hemodynamic Events Following Intravascular Infusion of Recombinant Adenovirus Reveals Possible Solutions for Mitigating Cardiovascular Responses

Adenoviral Delivery of Human and Viral IL-10 in Murine Sepsis

Working Toward an Adenoviral Vector Testing Standard

Recombinant adenovirus-transduced human dendritic cells engineered to secrete interleukin-10 (IL-10) suppress Th1-type responses while selectively activating IL-10—producing CD4 + T cells

Functional modification of dendritic cells with recombinant adenovirus encoding interleukin 10 for the treatment of sepsis

897. The development of standards for cell and gene therapy products: The activities of the United States pharmacopeia

Assessment of p53 gene transfer and biological activities in a clinical study of adenovirus-p53 gene therapy for recurrent ovarian cancer

Making the (clinical) grade with adenoviral gene therapy vectors

Extended lung expression and increased tissue localization of viral IL-10 with adenoviral gene therapy

Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models

Suchergebnisse filtern